1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FFFC2002FB8DDE9C85256DD70057F298
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/case-studies-of-pharmaceutical-megabrands?opendocument
18
19opendocument
2034.230.84.215
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Planning and Coordinating Launch Launch Strategy and Structure

Case Studies of Pharmaceutical Megabrands

DB Image

ID: 4516


Features:


Words: 14,322


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 38-page document includes 16 case studies on the success of various pharmaceutical products that have been launched in the last few years. Learn the marketing profiles, tactics and strategies that made these products into blockbusters. Products studied include Lipitor, Allegra, Botox and Cipro. This research originated from Best Practices, LLC's consulting services.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care


Companies Profiled:
GlaxoSmithKline; Sanofi-aventis; Eli Lilly; Ortho Biotech; Bristol-Myers Squibb; AstraZeneca; Schering-Plough; Bayer; Merck; Pharmacia; Allergan; Pfizer


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.